NCT06743633Not yet recruiting
Association of Beta Blocker Use with Depressive Outcomes
An Observational Study to Explore the Association Between Beta Blocker Use and Depressive Outcomes
Source: ClinicalTrials.gov · Last updated 20 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
An Observational Study to Explore the Association Between β-Blocker Use and Depressive Outcomes
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1136 (estimated)
- First submitted
- 17 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Chitkara University
- Diseases
- Depression
- NCT number
- NCT06743633
What you commit to
- Study type: Observational
- Planned participants: 1136
- From 1 Jan 2025 to the primary completion date, 30 Apr 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Depression with other psychiatric illness for e.g., schizophrenia, cognitive impairment and without any cardiac comorbidity.
Other
- 1\. Having severe sensory and physical limitations, severe disconnection from the environment, or presence of severe neuropsychiatric symptoms that make it impossible to administer the assessment.
- For Retrospective Study:-
Who the study is looking for
- Participants aged from ≥18 years at the time of consent.
- Participants on β-blockers for at least 1 year.
- No significant cognitive impairment.
- Participants who are willing to participate.
- To be able to understand and answer the self-assessment questionnaires.
- Diagnosis with major depressive disorder or reference to "clinical depression" in patient charts.
- Participants with cardiovascular co-morbidity.
- Participants aged from ≥18 years.
Criteria the registry did not label
- For Prospective Study:-
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.